Global Community
Our community narratives are driven by numbers and valuation.
Community Investing Ideas
Global Weekly Picks
US$2.21
FV
50.2% undervalued intrinsic discount119.00%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
4users have followed this narrative
New narrative
US$500.00
FV
3.4% overvalued intrinsic discount6.75%
Revenue growth p.a.
7users have liked this narrative
1users have commented on this narrative
16users have followed this narrative
8 days ago author updated this narrative
US$234.75
FV
1.4% undervalued intrinsic discount13.60%
Revenue growth p.a.
8users have liked this narrative
1users have commented on this narrative
8users have followed this narrative
New narrative
€4.02
FV
47.4% undervalued intrinsic discount8.50%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
Updated narrative
UK£0.58
FV
68.2% undervalued intrinsic discount0.87%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
15users have followed this narrative
27 days ago author updated this narrative
UK£0.04
FV
19.1% undervalued intrinsic discount-19.68%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
27 days ago author updated this narrative
US$29.00
FV
95.7% undervalued intrinsic discount24.08%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
27 days ago author updated this narrative
AU$0.18
FV
22.2% undervalued intrinsic discount86.30%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
3users have followed this narrative
27 days ago author updated this narrative
AN
Consensus Narrative from Analysts
New Indoor Cultivation Facilities In Ocala Will Improve Operations
Key Takeaways Investment in core brands and new cultivation facilities aims to enhance product quality and drive revenue growth. Streamlining operations and cost control are expected to improve operational efficiency and profitability.
View narrativeCA$0.40
FV
61.3% undervalued intrinsic discount0.49%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
27 days ago author updated this narrative
CA$3.82
FV
22.5% undervalued intrinsic discount4.27%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
27 days ago author updated this narrative
AN
Consensus Narrative from 12 Analysts
ZURZUVAE Commercialization And OB/GYN Screening Will Unlock New Opportunities
Key Takeaways Commercialization of ZURZUVAE and increased healthcare provider focus on PPD could significantly drive revenue growth. Restructured R&D focus and cost-saving initiatives may enhance pipeline development and improve financial performance.
View narrativeUS$8.73
FV
0.6% undervalued intrinsic discount50.99%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
5users have followed this narrative
27 days ago author updated this narrative
US$7.56
FV
36.2% undervalued intrinsic discount4.63%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
8users have followed this narrative
27 days ago author updated this narrative
US$44.00
FV
0.02% undervalued intrinsic discount3.99%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
3users have followed this narrative
27 days ago author updated this narrative